Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-08-05
1996-09-24
Patterson, Jr., Charles L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530399, 435 691, 435 698, A61K 3818, C07K 14495, C07K 1453, C12P 2106
Patent
active
055590934
ABSTRACT:
A method of increasing platelets in mammals which comprises administering to mammals an effective amount of a heparin-binding secretory transforming factor 1 protein (hst-1) having an N-terminal deletion of 27 amino acids.
REFERENCES:
Iida et al. 1992 Oncogene 7(2): 303-309
Igarashi Koichi
Kurokawa Tsutomu
Yoshitomi Sumie
Carlson Karen Cochrane
Conlin David G.
Eisenstein Ronald I.
Patterson Jr. Charles L.
Takeda Chemical Industries Ltd.
LandOfFree
N-terminally truncated hst-1 is a platelet-increasing factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-terminally truncated hst-1 is a platelet-increasing factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-terminally truncated hst-1 is a platelet-increasing factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928468